Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor Signaling
Amanda L. Gavin,1Kasper Hoebe,1Bao Duong,1,2Takayuki Ota,1Christopher Martin,1,2Bruce Beutler,1David Nemazee1*
Innate immune signals mediated by Toll-like receptors (TLRs)have been thought to contribute considerably to the antibody-enhancingeffects of vaccine adjuvants. However, we report here that micedeficient in the critical signaling components for TLR mountrobust antibody responses to T celldependent antigengiven in four typical adjuvants: alum, Freund's complete adjuvant,Freund's incomplete adjuvant, and monophosphoryl-lipid A/trehalosedicorynomycolate adjuvant. We conclude that TLR signaling doesnot account for the action of classical adjuvants and does notfully explain the action of a strong adjuvant containing a TLRligand. This may have important implications in the use anddevelopment of vaccine adjuvants.
1 Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037 USA. 2 The Scripps Research Institute, Kellogg School of Science and Technology, Doctoral Program in Chemical and Biological Sciences, La Jolla, CA 92037, USA.
* To whom correspondence should be addressed. E-mail: nemazee{at}scripps.edu
The editors suggest the following Related Resources on Science sites:
In Science Magazine
NEWS OF THE WEEK
Ingrid Wickelgren (22 December 2006) Science314 (5807), 1859a.
[DOI: 10.1126/science.314.5807.1859a] |Summary »|Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Transverse myelitis and vaccines: a multi-analysis.
N. Agmon-Levin, S. Kivity, M. Szyper-Kravitz, and Y. Shoenfeld (2009)
Lupus
18, 1198-1204
|Abstract »|PDF »
Adjuvants and autoimmunity.
E. Israeli, N. Agmon-Levin, M. Blank, and Y. Shoenfeld (2009)
Lupus
18, 1217-1225
|Abstract »|PDF »
CD4 T cell cooperation is required for the in vivo activation of CD4 T cells.
N. C. Peters, D. R. Kroeger, S. Mickelwright, and P. A. Bretscher (2009)
Int. Immunol.
21, 1213-1224
|Abstract »|Full Text »|PDF »
Adjuvants Induce Distinct Immunological Phenotypes in a Bovine Tuberculosis Vaccine Model.
H. M. Vordermeier, G. S. Dean, I. Rosenkrands, E. M. Agger, P. Andersen, D. A. Kaveh, R. G. Hewinson, and P. J. Hogarth (2009)
Clin. Vaccine Immunol.
16, 1443-1448
|Abstract »|Full Text »|PDF »
Alum Induces Innate Immune Responses through Macrophage and Mast Cell Sensors, But These Sensors Are Not Required for Alum to Act As an Adjuvant for Specific Immunity.
A. S. McKee, M. W. Munks, M. K. L. MacLeod, C. J. Fleenor, N. Van Rooijen, J. W. Kappler, and P. Marrack (2009)
J. Immunol.
183, 4403-4414
|Abstract »|Full Text »|PDF »
Alveolar Macrophages and Lung Dendritic Cells Sense RNA and Drive Mucosal IgA Responses.
J. Bessa, A. Jegerlehner, H. J. Hinton, P. Pumpens, P. Saudan, P. Schneider, and M. F. Bachmann (2009)
J. Immunol.
183, 3788-3799
|Abstract »|Full Text »|PDF »
Vaccine-Induced Antibody Isotypes Are Skewed by Impaired CD4 T Cell and Invariant NKT Cell Effector Responses in MyD88-Deficient Mice.
O. I. Iweala, D. W. Smith, K. S. Matharu, I. Sada-Ovalle, D. D. Nguyen, R. H. DeKruyff, D. T. Umetsu, S. M. Behar, and C. R. Nagler (2009)
J. Immunol.
183, 2252-2260
|Abstract »|Full Text »|PDF »
Novel Generation Mycobacterial Adjuvant Based on Liposome-Encapsulated Monomycoloyl Glycerol from Mycobacterium bovis Bacillus Calmette-Guerin.
C. A. S. Andersen, I. Rosenkrands, A. W. Olsen, P. Nordly, D. Christensen, R. Lang, C. Kirschning, J. M. Gomes, V. Bhowruth, D. E. Minnikin, et al. (2009)
J. Immunol.
183, 2294-2302
|Abstract »|Full Text »|PDF »
Concomitant Inhalation of Cigarette Smoke and Aerosolized Protein Activates Airway Dendritic Cells and Induces Allergic Airway Inflammation in a TLR-Independent Way.
L. J. Robays, E. A. Lanckacker, K. B. Moerloose, T. Maes, K. R. Bracke, G. G. Brusselle, G. F. Joos, and K. Y. Vermaelen (2009)
J. Immunol.
183, 2758-2766
|Abstract »|Full Text »|PDF »
Innate and Adaptive Immunity Cooperate Flexibly to Maintain Host-Microbiota Mutualism.
E. Slack, S. Hapfelmeier, B. Stecher, Y. Velykoredko, M. Stoel, M. A. E. Lawson, M. B. Geuking, B. Beutler, T. F. Tedder, W.-D. Hardt, et al. (2009)
Science
325, 617-620
|Abstract »|Full Text »|PDF »
Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus.
D. H. Kono, M. K. Haraldsson, B. R. Lawson, K. M. Pollard, Y. T. Koh, X. Du, C. N. Arnold, R. Baccala, G. J. Silverman, B. A. Beutler, et al. (2009)
PNAS
106, 12061-12066
|Abstract »|Full Text »|PDF »
B Cell Intrinsic MyD88 Signals Drive IFN-{gamma} Production from T Cells and Control Switching to IgG2c.
T. A. Barr, S. Brown, P. Mastroeni, and D. Gray (2009)
J. Immunol.
183, 1005-1012
|Abstract »|Full Text »|PDF »
Interaction of the Hepatitis B Core Antigen and the Innate Immune System.
B. O. Lee, A. Tucker, L. Frelin, M. Sallberg, J. Jones, C. Peters, J. Hughes, D. Whitacre, B. Darsow, D. L. Peterson, et al. (2009)
J. Immunol.
182, 6670-6681
|Abstract »|Full Text »|PDF »
The Mucosal Adjuvant Effect of {alpha}-Galactosylceramide for Induction of Protective Immunity to Sexually Transmitted Viral Infection.
M. Lindqvist, J. Persson, K. Thorn, and A. M. Harandi (2009)
J. Immunol.
182, 6435-6443
|Abstract »|Full Text »|PDF »
BCR-mediated uptake of antigen linked to TLR9 ligand stimulates B-cell proliferation and antigen-specific plasma cell formation.
Comparing Pooled Peptides with Intact Protein for Accessing Cross-presentation Pathways for Protective CD8+ and CD4+ T Cells.
H. Zhang, H. Hong, D. Li, S. Ma, Y. Di, A. Stoten, N. Haig, K. Di Gleria, Z. Yu, X.-N. Xu, et al. (2009)
J. Biol. Chem.
284, 9184-9191
|Abstract »|Full Text »|PDF »
Trif is not required for immune complex glomerulonephritis: dying cells activate mesangial cells via Tlr2/Myd88 rather than Tlr3/Trif.
J. Lichtnekert, V. Vielhauer, D. Zecher, O. P. Kulkarni, S. Clauss, S. Segerer, V. Hornung, T. N. Mayadas, B. Beutler, S. Akira, et al. (2009)
Am J Physiol Renal Physiol
296, F867-F874
|Abstract »|Full Text »|PDF »
Immunostimulatory activity of haptenated proteins.
Antigen-specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protection against F. tularensis LVS challenge.
L. E. Cole, Y. Yang, K. L. Elkins, E. T. Fernandez, N. Qureshi, M. J. Shlomchik, L. A. Herzenberg, L. A. Herzenberg, and S. N. Vogel (2009)
PNAS
106, 4343-4348
|Abstract »|Full Text »|PDF »
NK Cell Enhancement of Antigen Presentation by B Lymphocytes.
Innate Immunity Mediated by MyD88 Signal Is Not Essential for Induction of Lipopolysaccharide-Specific B Cell Responses but Is Indispensable for Protection against Salmonella enterica serovar Typhimurium infection.
H.-J. Ko, J.-Y. Yang, D.-H. Shim, H. Yang, S.-M. Park, R. Curtiss III, and M.-N. Kweon (2009)
J. Immunol.
182, 2305-2312
|Abstract »|Full Text »|PDF »
Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome.
F. A. Sharp, D. Ruane, B. Claass, E. Creagh, J. Harris, P. Malyala, M. Singh, D. T. O'Hagan, V. Petrilli, J. Tschopp, et al. (2009)
PNAS
106, 870-875
|Abstract »|Full Text »|PDF »
Where Asthma and Hypersensitivity Pneumonitis Meet and Differ: Noneosinophilic Severe Asthma.
P. Bogaert, K. G. Tournoy, T. Naessens, and J. Grooten (2009)
Am. J. Pathol.
174, 3-13
|Abstract »|Full Text »|PDF »
CTA1-DD adjuvant promotes strong immunity against human immunodeficiency virus type 1 envelope glycoproteins following mucosal immunization.
C. Sundling, K. Schon, A. Morner, M. N. E. Forsell, R. T. Wyatt, R. Thorstensson, G. B. K. Hedestam, and N. Y. Lycke (2008)
J. Gen. Virol.
89, 2954-2964
|Abstract »|Full Text »|PDF »
MyD88 Signaling Is Not Essential for Induction of Antigen-Specific B Cell Responses but Is Indispensable for Protection against Streptococcus pneumoniae Infection following Oral Vaccination with Attenuated Salmonella Expressing PspA Antigen.
S.-M. Park, H.-J. Ko, D.-H. Shim, J.-Y. Yang, Y.-H. Park, R. Curtiss III, and M.-N. Kweon (2008)
J. Immunol.
181, 6447-6455
|Abstract »|Full Text »|PDF »
Cutting Edge: Alum Adjuvant Stimulates Inflammatory Dendritic Cells through Activation of the NALP3 Inflammasome.
M. Kool, V. Petrilli, T. De Smedt, A. Rolaz, H. Hammad, M. van Nimwegen, I. M. Bergen, R. Castillo, B. N. Lambrecht, and J. Tschopp (2008)
J. Immunol.
181, 3755-3759
|Abstract »|Full Text »|PDF »
Toll-like receptors: lessons to learn from normal and malignant human B cells.
D. Chiron, I. Bekeredjian-Ding, C. Pellat-Deceunynck, R. Bataille, and G. Jego (2008)
Blood
112, 2205-2213
|Abstract »|Full Text »|PDF »
TLR Adaptor MyD88 Is Essential for Pathogen Control during Oral Toxoplasma gondii Infection but Not Adaptive Immunity Induced by a Vaccine Strain of the Parasite.
W. Sukhumavasi, C. E. Egan, A. L. Warren, G. A. Taylor, B. A. Fox, D. J. Bzik, and E. Y. Denkers (2008)
J. Immunol.
181, 3464-3473
|Abstract »|Full Text »|PDF »
Endoplasmic reticulum HSP90b1 (gp96, grp94) optimizes B-cell function via chaperoning integrin and TLR but not immunoglobulin.
Pyogenic Bacterial Infections in Humans with MyD88 Deficiency.
H. von Bernuth, C. Picard, Z. Jin, R. Pankla, H. Xiao, C.-L. Ku, M. Chrabieh, I. B. Mustapha, P. Ghandil, Y. Camcioglu, et al. (2008)
Science
321, 691-696
|Abstract »|Full Text »|PDF »
Differential Activation of Human and Mouse Toll-Like Receptor 4 by the Adjuvant Candidate LpxL1 of Neisseria meningitidis.
L. Steeghs, A. M. Keestra, A. van Mourik, H. Uronen-Hansson, P. van der Ley, R. Callard, N. Klein, and J. P. M. van Putten (2008)
Infect. Immun.
76, 3801-3807
|Abstract »|Full Text »|PDF »
The Agonists of TLR4 and 9 Are Sufficient to Activate Memory B Cells to Differentiate into Plasma Cells In Vitro but Not In Vivo.
Molecular and cellular signatures of human vaccine adjuvants.
F. Mosca, E. Tritto, A. Muzzi, E. Monaci, F. Bagnoli, C. Iavarone, D. O'Hagan, R. Rappuoli, and E. De Gregorio (2008)
PNAS
105, 10501-10506
|Abstract »|Full Text »|PDF »
Cutting Edge: Inflammasome Activation by Alum and Alum's Adjuvant Effect Are Mediated by NLRP3.
H. Li, S. B. Willingham, J. P.-Y. Ting, and F. Re (2008)
J. Immunol.
181, 17-21
|Abstract »|Full Text »|PDF »
Viral Double-Stranded RNA Triggers Ig Class Switching by Activating Upper Respiratory Mucosa B Cells through an Innate TLR3 Pathway Involving BAFF.
W. Xu, P. A. Santini, A. J. Matthews, A. Chiu, A. Plebani, B. He, K. Chen, and A. Cerutti (2008)
J. Immunol.
181, 276-287
|Abstract »|Full Text »|PDF »
Requirements for the natural killer cell-mediated induction of IgG1 and IgG2a expression in B lymphocytes.
Gr1+IL-4-producing innate cells are induced in response to Th2 stimuli and suppress Th1-dependent antibody responses.
A. S. McKee, M. MacLeod, J. White, F. Crawford, J. W. Kappler, and P. Marrack (2008)
Int. Immunol.
20, 659-669
|Abstract »|Full Text »|PDF »
Role for MyD88 Signaling in Murine Gammaherpesvirus 68 Latency.
L. M. Gargano, J. M. Moser, and S. H. Speck (2008)
J. Virol.
82, 3853-3863
|Abstract »|Full Text »|PDF »
The Adjuvants Aluminum Hydroxide and MF59 Induce Monocyte and Granulocyte Chemoattractants and Enhance Monocyte Differentiation toward Dendritic Cells.
A. Seubert, E. Monaci, M. Pizza, D. T. O'Hagan, and A. Wack (2008)
J. Immunol.
180, 5402-5412
|Abstract »|Full Text »|PDF »
Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells.
M. Kool, T. Soullie, M. van Nimwegen, M. A.M. Willart, F. Muskens, S. Jung, H. C. Hoogsteden, H. Hammad, and B. N. Lambrecht (2008)
J. Exp. Med.
205, 869-882
|Abstract »|Full Text »|PDF »
Pivotal Advance: Eosinophils mediate early alum adjuvant-elicited B cell priming and IgM production.
TLR Agonists Promote Marginal Zone B Cell Activation and Facilitate T-Dependent IgM Responses.
A. V. Rubtsov, C. L. Swanson, S. Troy, P. Strauch, R. Pelanda, and R. M. Torres (2008)
J. Immunol.
180, 3882-3888
|Abstract »|Full Text »|PDF »
Colonic Patches Direct the Cross-Talk Between Systemic Compartments and Large Intestine Independently of Innate Immunity.
S.-Y. Chang, H.-R. Cha, S. Uematsu, S. Akira, O. Igarashi, H. Kiyono, and M.-N. Kweon (2008)
J. Immunol.
180, 1609-1618
|Abstract »|Full Text »|PDF »
Ets-1 Regulates Plasma Cell Differentiation by Interfering with the Activity of the Transcription Factor Blimp-1.
S. A. John, J. L. Clements, L. M. Russell, and L. A. Garrett-Sinha (2008)
J. Biol. Chem.
283, 951-962
|Abstract »|Full Text »|PDF »
Interleukin-15 Increases Vaccine Efficacy through a Mechanism Linked to Dendritic Cell Maturation and Enhanced Antibody Titers.
K. U. Saikh, T. L. Kissner, S. Nystrom, G. Ruthel, and R. G. Ulrich (2008)
Clin. Vaccine Immunol.
15, 131-137
|Abstract »|Full Text »|PDF »
Receptor for Advanced Glycation End Products Expression on T Cells Contributes to Antigen-Specific Cellular Expansion In Vivo.
B. Moser, D. D. Desai, M. P. Downie, Y. Chen, S. F. Yan, K. Herold, A. M. Schmidt, and R. Clynes (2007)
J. Immunol.
179, 8051-8058
|Abstract »|Full Text »|PDF »
Agonists of Toll-Like Receptors 3, 4, 7, and 9 Are Candidates for Use as Adjuvants in an Outer Membrane Vaccine against Neisseria meningitidis Serogroup B.
F. Fransen, C. J. Boog, J. P. van Putten, and P. van der Ley (2007)
Infect. Immun.
75, 5939-5946
|Abstract »|Full Text »|PDF »
A protein associated with Toll-like receptor (TLR) 4 (PRAT4A) is required for TLR-dependent immune responses.
K. Takahashi, T. Shibata, S. Akashi-Takamura, T. Kiyokawa, Y. Wakabayashi, N. Tanimura, T. Kobayashi, F. Matsumoto, R. Fukui, T. Kouro, et al. (2007)
J. Exp. Med.
204, 2963-2976
|Abstract »|Full Text »|PDF »
The Lipopolysaccharide Adjuvant Effect on T Cells Relies on Nonoverlapping Contributions from the MyD88 Pathway and CD11c+ Cells.
J. P. McAleer, D. J. Zammit, L. Lefrancois, R. J. Rossi, and A. T. Vella (2007)
J. Immunol.
179, 6524-6535
|Abstract »|Full Text »|PDF »
Primary Development and Participation in a Foreign Antigen-Driven Immune Response of a Chromatin-Reactive B Cell Clonotype Are Not Influenced by TLR9 or Other MyD88-Dependent TLRs.
Danger-free autoimmune disease in Aire-deficient mice.
D. H. D. Gray, I. Gavanescu, C. Benoist, and D. Mathis (2007)
PNAS
104, 18193-18198
|Abstract »|Full Text »|PDF »
Autoimmunity Stimulated by Adoptively Transferred Dendritic Cells Is Initiated by Both {alpha}beta and {gamma}{delta} T Cells but Does Not Require MyD88 Signaling.
D. A. Martin, K. Zhang, J. Kenkel, G. Hughes, E. Clark, A. Davidson, and K. B. Elkon (2007)
J. Immunol.
179, 5819-5828
|Abstract »|Full Text »|PDF »
Selective predisposition to bacterial infections in IRAK-4 deficient children: IRAK-4 dependent TLRs are otherwise redundant in protective immunity.
C.-L. Ku, H. von Bernuth, C. Picard, S.-Y. Zhang, H.-H. Chang, K. Yang, M. Chrabieh, A. C. Issekutz, C. K. Cunningham, J. Gallin, et al. (2007)
J. Exp. Med.
204, 2407-2422
|Abstract »|Full Text »|PDF »
Sustained antigen presentation can promote an immunogenic T cell response, like dendritic cell activation.
R. Obst, H.-M. van Santen, R. Melamed, A. O. Kamphorst, C. Benoist, and D. Mathis (2007)
PNAS
104, 15460-15465
|Abstract »|Full Text »|PDF »
Neisseria meningitidis PorB, a TLR2 Ligand, Induces an Antigen-Specific Eosinophil Recall Response: Potential Adjuvant for Helminth Vaccines?.
J. M. Burke, L. M. Ganley-Leal, A. Khatri, and L. M. Wetzler (2007)
J. Immunol.
179, 3222-3230
|Abstract »|Full Text »|PDF »
BAFF and MyD88 signals promote a lupuslike disease independent of T cells.
J. R. Groom, C. A. Fletcher, S. N. Walters, S. T. Grey, S. V. Watt, M. J. Sweet, M. J. Smyth, C. R. Mackay, and F. Mackay (2007)
J. Exp. Med.
204, 1959-1971
|Abstract »|Full Text »|PDF »
The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4.
V. Mata-Haro, C. Cekic, M. Martin, P. M. Chilton, C. R. Casella, and T. C. Mitchell (2007)
Science
316, 1628-1632
|Abstract »|Full Text »|PDF »
TLR Agonists Selectively Promote Terminal Plasma Cell Differentiation of B Cell Subsets Specialized in Thymus-Independent Responses.
L. Genestier, M. Taillardet, P. Mondiere, H. Gheit, C. Bella, and T. Defrance (2007)
J. Immunol.
178, 7779-7786
|Abstract »|Full Text »|PDF »
Salmonella Induces a Switched Antibody Response without Germinal Centers That Impedes the Extracellular Spread of Infection.
A. F. Cunningham, F. Gaspal, K. Serre, E. Mohr, I. R. Henderson, A. Scott-Tucker, S. M. Kenny, M. Khan, K.-M. Toellner, P. J. L. Lane, et al. (2007)
J. Immunol.
178, 6200-6207
|Abstract »|Full Text »|PDF »
Tolls and Beyond -- Many Roads to Vaccine Immunity.
B. Pulendran (2007)
N. Engl. J. Med.
356, 1776-1778
|Full Text »|PDF »
Viral induction of AID is independent of the interferon and the Toll-like receptor signaling pathways but requires NF-{kappa}B.
P. Gourzi, T. Leonova, and F. N. Papavasiliou (2007)
J. Exp. Med.
204, 259-265
|Abstract »|Full Text »|PDF »